Exploring the Structural Rearrangements of the Human Insulin-Degrading Enzyme through Molecular Dynamics Simulations

Insulin-degrading enzyme (IDE) is a ubiquitously expressed metallopeptidase that degrades insulin and a large panel of amyloidogenic peptides. IDE is thought to be a potential therapeutic target for type-2 diabetes and neurodegenerative diseases, such as Alzheimer’s disease. IDE catalytic chamber, k...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghoula, Mariem, Janel, Nathalie, Camproux, Anne-Claude, Moroy, Gautier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836115/
https://www.ncbi.nlm.nih.gov/pubmed/35163673
http://dx.doi.org/10.3390/ijms23031746

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836115/
https://www.ncbi.nlm.nih.gov/pubmed/35163673
http://dx.doi.org/10.3390/ijms23031746

Ejemplares similares